奥精医疗
(688613)
| 流通市值：21.92亿 | | | 总市值：21.92亿 |
| 流通股本：1.37亿 | | | 总股本：1.37亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 104,064,611.26 | 48,679,881.28 | 223,736,817.67 | 156,057,979.41 |
| 营业总成本 | 108,570,712.61 | 50,705,307.96 | 233,158,629.73 | 162,013,922.68 |
| 其他经营收益 | | | | |
| 营业利润 | 1,108,766.23 | 1,139,795.72 | 11,998,367.28 | 10,718,896.72 |
| 利润总额 | 1,407,202.94 | 1,138,692.17 | 12,287,556.58 | 10,746,561.57 |
| 净利润 | 1,175,650.85 | 518,605.8 | 9,502,355 | 10,595,768.44 |
| 每股收益 | | | | |
| 其他综合收益 | -562,316.5 | -389,686.31 | 444,836.95 | 770,228.41 |
| 综合收益总额 | 613,334.35 | 128,919.49 | 9,947,191.95 | 11,365,996.85 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,192,345,636.27 | 1,167,895,886.39 | 1,223,537,997.71 | 1,215,045,444.13 |
| 非流动资产: | | | | |
| 非流动资产合计 | 329,112,269.7 | 337,073,941.62 | 340,345,404.6 | 329,790,641.01 |
| 资产总计 | 1,521,457,905.97 | 1,504,969,828.01 | 1,563,883,402.31 | 1,544,836,085.14 |
| 流动负债: | | | | |
| 流动负债合计 | 26,595,072.54 | 21,955,068.88 | 81,980,326.93 | 67,944,068.11 |
| 非流动负债: | | | | |
| 非流动负债合计 | 46,890,894.55 | 35,527,235.11 | 34,544,470.85 | 28,114,607.6 |
| 负债合计 | 73,485,967.09 | 57,482,303.99 | 116,524,797.78 | 96,058,675.71 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,436,799,019.9 | 1,435,628,041.87 | 1,434,606,753.54 | 1,435,033,515.43 |
| 股东权益合计 | 1,447,971,938.88 | 1,447,487,524.02 | 1,447,358,604.53 | 1,448,777,409.43 |
| 负债和股东权益合计 | 1,521,457,905.97 | 1,504,969,828.01 | 1,563,883,402.31 | 1,544,836,085.14 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 91,759,116.96 | 41,916,335.05 | 304,522,390.17 | 199,654,480.02 |
| 经营活动现金流出小计 | 143,205,934.26 | 73,091,006.13 | 265,030,535.78 | 204,151,572.55 |
| 经营活动产生的现金流量净额 | -51,446,817.3 | -31,174,671.07 | 39,491,854.39 | -4,497,092.53 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 6,167,550.62 | 90 | 25,124,628.64 | 25,040,001.48 |
| 投资活动现金流出小计 | 5,070,934.46 | 1,214,756.56 | 58,927,434.23 | 47,968,305.54 |
| 投资活动产生的现金流量净额 | 1,096,616.16 | -1,214,666.56 | -33,802,805.59 | -22,928,304.06 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 15,000,000 | - | 14,705,486.43 | 14,705,486.43 |
| 筹资活动现金流出小计 | 34,964,980.62 | 33,356,670.96 | 8,440,659.43 | 6,461,259.23 |
| 筹资活动产生的现金流量净额 | -19,964,980.62 | -33,356,670.96 | 6,264,827 | 8,244,227.2 |
| 汇率变动对现金及现金等价物的影响 | -58,768.74 | -23,176.06 | 395,521.51 | 409,595.3 |
| 现金及现金等价物净增加额 | -70,373,950.5 | -65,769,184.65 | 12,349,397.31 | -18,771,574.09 |
| 期末现金及现金等价物余额 | 98,689,879.52 | 103,294,645.37 | 169,063,830.02 | 137,942,858.62 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -70,373,950.5 | - | 12,349,397.31 | - |